EPIDEMIOLOGICAL ASSESSMENT OF ANTIMICROBIAL RESISTANCE IN HOSPITAL-ACQUIRED INFECTIONS IN CENTRAL IRAQ
Downloads
Objective: Antimicrobial Resistance (AMR) of hospital-acquired infections (HAs) poses an urgent risk to patient safety in many countries and is not well characterized, especially in central Iraq. To this end, the following epidemiological assessment explores microbiota compositions, susceptibility patterns and risk-factors arising from tertiary hospitals throughout Baghdad and adjacent areas in 2023–2025 epochs. Method: In a systematic investigation of 8500 clinical samples from patients in an intensive care unit, surgical wards and internal medicine department, we identified that the overall rate of HAIs was 52%, with increasing rates seen in those who were ventilated or had longer lengths of stay. Methods Phylogenetic analysis of the clonal spread of MDR K. pneumoniae ST258-like strains between facilities. Results: The isolates were predominantly Gram-negative (62%, led by Klebsiella pneumoniae (35%), Escherichia coli (22%) and Acinetobacter baumannii (18%)), whereas Gram-positive such as Staphylococcus aureus (15%) and Enterococcus spp. (10%) were notable. Multi-drug resistance (MDR) was common: 73% isolates were MDR, 41% CRE and 52% MRSA. Ampicillin (more than 80%) cefotaxime and ciprofloxacin resistance were also common among Gram-negatives in the key resist profile, and raised concern of last resort therapy failure with 28% colistin resistance. Inappropriate use of antibiotics (70% pre-admission exposure), lack of infection control and noncompliance to hand hygiene rules (adherence 40%) were identified as risk factors. These findings indicate a growing AMR crisis driven by empirical prescribing and poor stewardship. Novelty: In the overburdened hospitals of central Iraq, HAIs require urgent interventions—national surveillance networks; rapid diagnostics; and bundled prevention strategies—to contain these infections and preserve therapeutic options.
World Health Organization, Global Action Plan on Antimicrobial Resistance. Geneva: WHO, 2020.
A. A. Al-Jumaili and K. K. Ahmed, “A review of antibiotic misuse and bacterial resistance in Iraq,” Eastern Mediterranean Health Journal, vol. 30, no. 10, pp. 789–801, 2024.
C. J. Murray et al., “Global burden of bacterial antimicrobial resistance in 2019,” The Lancet, vol. 399, no. 10325, pp. 629–655, 2022.
Centers for Disease Control and Prevention, Antibiotic Resistance Threats in the United States. U.S. Department of Health and Human Services, 2019.
M. Talaat et al., “Antimicrobial resistance in the Eastern Mediterranean Region,” Infection Control & Hospital Epidemiology, vol. 37, no. 8, pp. 945–952, 2016.
WHO Eastern Mediterranean Regional Office, AMR in the EMR: Country Profiles. Cairo: EMRO, 2022.
Institute for Health Metrics and Evaluation, The Burden of Antimicrobial Resistance in Iraq, 2023.
F. Al-Abbasi et al., “Analysis of bacterial resistance patterns in Mahmoudiyah hospitals,” Iraqi Academic Scientific Journals, vol. 12, no. 1, pp. 45–56, 2025.
Koya University Antimicrobial Resistance Surveillance Group, “Surveillance of antimicrobial resistance in Iraq,” Advanced Research Journal, p. 1689, 2024.
N. Hussein and S. Al-Mudhaffar, “Antibiotic use and resistance in Iraqi patients,” PMC Articles, PMC12327103, 2023.
M. Al-Sultani et al., “Antibiotic susceptibility and resistance in Karbala city hospitals,” International Journal of Biomedical and Pharmaceutical Sciences, vol. 4, no. 1, pp. 102–115, 2025.
Iraqi Ministry of Health, National AMR Surveillance Report. Baghdad: MoH Publications, 2023.
Al-Zahra University Research Group, “Comprehensive analysis of antibiotic-resistant infections in central Iraq,” Al-Zahra University Journal, vol. 8, no. 2, pp. 120–135, 2025.
D. A. Abbas, A. A. Alsaedi, B. A. Hadi, and M. H. Al-Safi, “Antimicrobial resistance patterns in bacterial isolates from hospital-acquired infections,” SAR Journal of Pathology and Microbiology, vol. 6, no. 6, pp. 248–254, 2025, doi: 10.36346/sarjpm.2025.v06i06.003.
E. Tacconelli et al., “Discovery, research, and development of new antibiotics,” WHO Bulletin, vol. 96, no. 5, pp. 332–340, 2018.
A. Rahman et al., “Assessing antimicrobial prescribing patterns in Dhi Qar hospitals,” Baghdad Journal of Pharmaceutical Sciences, vol. 7, no. 2, pp. 340–355, 2024.
Karbala Antimicrobial Surveillance Team, “Frequency of A. baumannii and P. aeruginosa in Baghdad,” Iraqi Journal of Medical Sciences, vol. 15, no. 3, pp. 200–212, 2025.
Copyright (c) 2026 Marwa Jabbar Mezher

This work is licensed under a Creative Commons Attribution 4.0 International License.














